Trial Profile

A Placebo-controlled Phase IIa Study of Orally Administered BGC20-0134/Pleneva TM (Structured Lipid) in Patients With RRMS

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 04 Apr 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs BGC 200134 (Primary)
Indications Multiple sclerosis
Focus Pharmacogenomic; Therapeutic Use
Sponsors BTG

Most Recent Events

09 Aug 2017 This trial has been Discontinued in Belgium, according to European Clinical Trials Database record.
15 Mar 2012 This trial is recruiting in Belgium, France and has discontinued in Germany.
05 Oct 2011 Results from patients who have completed the open-label extension are being analysed.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com